New rules expand access to glucose sensors for young people with type 1 diabetes and pregnant women
RFZO rules in force since June 9 preserve sensor eligibility after age 18 for people who qualified as children and extend it to patients first diagnosed with type 1 diabetes after 18 who take at least four insulin doses a day. They also cover patients on that therapy before conception, during pregnancy and for one year after childbirth.

